Medicines and Healthcare Products Regulatory Agency
London, United Kingdom
Purpose
to develop first International Standard for Influenza HA stalk based antibody to accelerating Universal flu vaccine development
Division
Global Health
Date
March 2018
Region Served
AMERICA, EUROPE
Committed amount
$365,529
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
22
Grantee location
London, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.